Thirdly, the serum NSE levels of patients with trauma, cardiovascular disease, cerebral infarction, cerebral hemorrhage and other diseases are also increased [34], so we think that dynamic monitoring of serum NSE level is more conducive to guide the treatment. This evidence concerns the gene ENO2 and cardiovascular disorder.